146 related articles for article (PubMed ID: 16423878)
21. Antibodies against the carboxyl-terminal end of the Trypanosoma cruzi ribosomal P proteins are pathogenic.
López Bergami P; Scaglione J; Levin MJ
FASEB J; 2001 Dec; 15(14):2602-12. PubMed ID: 11726536
[TBL] [Abstract][Full Text] [Related]
22. Cross-talk between anti-beta1-adrenoceptor antibodies in dilated cardiomyopathy and Chagas' heart disease.
Levin MJ; Hoebeke J
Autoimmunity; 2008 Sep; 41(6):429-33. PubMed ID: 18781468
[TBL] [Abstract][Full Text] [Related]
23. Immunocytochemical reaction of sera from chagasic patients against Trypanosoma cruzi, intestine of Triatoma infestans and normal human heart.
Gutiérrez LS; Burgos C; Bianchi R; Burgos MH
Medicina (B Aires); 1999; 59(3):231-7. PubMed ID: 10451560
[TBL] [Abstract][Full Text] [Related]
24. [Levels of anti-Gal antibodies in persons infected and non-infected with Trypanosoma cruzi. Probably induced by bacteria and by the parasite].
González J; Ramírez C; Seguel X; Gutiérrez B; Manque P; Porcile P; Neira I; Sagua H
Bol Chil Parasitol; 1995; 50(1-2):3-9. PubMed ID: 8573266
[TBL] [Abstract][Full Text] [Related]
25. Correlation between conformation and antibody binding: NMR structure of cross-reactive peptides from T. cruzi, human and L. braziliensis.
Soares MR; Bisch PM; Campos de Carvalho AC; Valente AP; Almeida FC
FEBS Lett; 2004 Feb; 560(1-3):134-40. PubMed ID: 14988012
[TBL] [Abstract][Full Text] [Related]
26. [Study of cases of leishmaniasis in the Province of Salta: evidences of mixed infection with Trypanosoma cruzi and Leishmania spp].
Chiaramonte MG; Zwirner NW; Caropresi SL; Heredia V; Taranto NJ; Malchiodi EL
Medicina (B Aires); 1996; 56(3):259-68. PubMed ID: 9035482
[TBL] [Abstract][Full Text] [Related]
27. Autoantibodies in Chagas' disease. An antibody cross-reactive with human and Trypanosoma cruzi ribosomal proteins.
Bonfa E; Viana VS; Barreto AC; Yoshinari NH; Cossermelli W
J Immunol; 1993 May; 150(9):3917-23. PubMed ID: 8473740
[TBL] [Abstract][Full Text] [Related]
28. Autoantibodies to neurotrophic receptors TrkA, TrkB and TrkC in patients with acute Chagas' disease.
Lu B; Luquetti AO; Rassi A; PereiraPerrin M
Scand J Immunol; 2010 Mar; 71(3):220-5. PubMed ID: 20415787
[TBL] [Abstract][Full Text] [Related]
29. Characterization of an immunodominant antigenic epitope from Trypanosoma cruzi as a biomarker of chronic Chagas' disease pathology.
Thomas MC; Fernández-Villegas A; Carrilero B; Marañón C; Saura D; Noya O; Segovia M; Alarcón de Noya B; Alonso C; López MC
Clin Vaccine Immunol; 2012 Feb; 19(2):167-73. PubMed ID: 22155766
[TBL] [Abstract][Full Text] [Related]
30. The beta1 adrenergic effects of antibodies against the C-terminal end of the ribosomal P2beta protein of Trypanosoma cruzi associate with a specific pattern of epitope recognition.
Lopez Bergami P; Gómez KA; Levy GV; Grippo V; Baldi A; Levin MJ
Clin Exp Immunol; 2005 Oct; 142(1):140-7. PubMed ID: 16178868
[TBL] [Abstract][Full Text] [Related]
31. Human recombinant antibodies against Trypanosoma cruzi ribosomal P2β protein.
Grippo V; Niborski LL; Gomez KA; Levin MJ
Parasitology; 2011 May; 138(6):736-47. PubMed ID: 21414241
[TBL] [Abstract][Full Text] [Related]
32. Anti-Trypanosoma cruzi antibody isotype profiles in patients with different clinical manifestations of Chagas' disease.
Morgan J; Dias JC; Gontijo ED; Bahia-Oliveira L; Correa-Oliveira R; Colley DG; Powell MR
Am J Trop Med Hyg; 1996 Oct; 55(4):355-9. PubMed ID: 8916788
[TBL] [Abstract][Full Text] [Related]
33. Chagas' disease: Trypanosoma cruzi vs. the host immune system.
Hontebeyrie-Joskowicz M; Minoprio P
Res Immunol; 1991 Feb; 142(2):125-6. PubMed ID: 1907752
[No Abstract] [Full Text] [Related]
34. Functionally active cardiac antibodies in chronic Chagas' disease are specifically blocked by Trypanosoma cruzi antigens.
Masuda MO; Levin M; De Oliveira SF; Dos Santos Costa PC; Bergami PL; Dos Santos Almeida NA; Pedrosa RC; Ferrari I; Hoebeke J; Campos de Carvalho AC
FASEB J; 1998 Nov; 12(14):1551-8. PubMed ID: 9806764
[TBL] [Abstract][Full Text] [Related]
35. Chagas' disease: IgG isotypes against cytoplasmic (CRA) and flagellar (FRA) recombinant repetitive antigens of Trypanosoma cruzi in chronic Chagasic patients.
Verçosa AF; Lorena VM; Carvalho CL; Melo MF; Cavalcanti MG; Silva ED; Ferreira AG; Pereira VR; Souza WV; Gomes YM
J Clin Lab Anal; 2007; 21(5):271-6. PubMed ID: 17847109
[TBL] [Abstract][Full Text] [Related]
36. β1-selective adrenoceptor antagonists increase plasma levels of anti-p2β antibodies and decrease cardiac involvement in chronic progressive Chagas heart disease.
Vicco MH; Pujato N; Bontempi I; Rodeles L; Marcipar I; Bottasso OA
Can J Cardiol; 2014 Mar; 30(3):332-7. PubMed ID: 24370375
[TBL] [Abstract][Full Text] [Related]
37. Antigens of Trypanosoma cruzi that mimic mammalian nervous tissues: investigations of their role in the autoimmune pathophysiology of chronic Chagas' disease.
Petry K; Van Voorhis WC
Res Immunol; 1991 Feb; 142(2):151-6. PubMed ID: 1714088
[No Abstract] [Full Text] [Related]
38. Humoral and cellular immune responses to Trypanosoma cruzi-derived paraflagellar rod proteins in patients with Chagas' disease.
Michailowsky V; Luhrs K; Rocha MO; Fouts D; Gazzinelli RT; Manning JE
Infect Immun; 2003 Jun; 71(6):3165-71. PubMed ID: 12761095
[TBL] [Abstract][Full Text] [Related]
39. A monoclonal antibody against the immunodominant epitope of the ribosomal P2beta protein of Trypanosoma cruzi interacts with the human beta 1-adrenergic receptor.
Mahler E; Sepulveda P; Jeannequin O; Liegeard P; Gounon P; Wallukat G; Eftekhari P; Levin MJ; Hoebeke J; Hontebeyrie M
Eur J Immunol; 2001 Jul; 31(7):2210-6. PubMed ID: 11449375
[TBL] [Abstract][Full Text] [Related]
40. Interaction of human chagasic IgG with the second extracellular loop of the human heart muscarinic acetylcholine receptor: functional and pathological implications.
Goin JC; Leiros CP; Borda E; Sterin-Borda L
FASEB J; 1997 Jan; 11(1):77-83. PubMed ID: 9034169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
